» Articles » PMID: 25921831

The Role of the Gut Microbiota in Metabolic Health

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2015 Apr 30
PMID 25921831
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

The global prevalence of obesity and related comorbidities has increased considerably over the past decades. In addition to an increase in food consumption and a reduction in physical activity, growing evidence implicates the microorganisms in our gastrointestinal tract, referred to as the gut microbiota, in obesity and related metabolic disturbances. The composition of the gut microbiota can fluctuate markedly within an individual and between individuals. Changes in gut microbial composition may be unfavorable and predispose an individual to disease. Studies in mice that are germ free, mice that are cohoused, and mice that are treated with antibiotics have provided some evidence that changes in gut microbiota may causally contribute to metabolic disorders. Several mechanisms have been proposed and explored that may mediate the effects of the gut microbiota on metabolic disorders. In this review, we carefully analyze the literature on the connection between the gut microbiota and metabolic health, with a focus on studies demonstrating a causal relation and clarifying potential underlying mechanisms. Despite a growing appreciation for a role of the gut microbiota in metabolic health, more experimental evidence is needed to substantiate a cause-and-effect relationship. If a clear causal relationship between the gut microbiota and metabolic health can be established, dietary interventions can be targeted toward improving gut microbial composition in the prevention and perhaps even the treatment of metabolic diseases.

Citing Articles

Interactions between gut microbes and host promote degradation of various fiber components in Meishan pigs.

Pu G, Hou L, Zhao Q, Liu G, Wang Z, Zhou W mSystems. 2025; 10(2):e0150024.

PMID: 39873521 PMC: 11834408. DOI: 10.1128/msystems.01500-24.


Effects of prebiotic and multispecies probiotic supplementation on the gut microbiota, immune function, and growth performance of weaned piglets.

Huaman S, de Souza F, Bonato M, Dias C, Callegari M, Oba A PLoS One. 2024; 19(11):e0313475.

PMID: 39570882 PMC: 11581253. DOI: 10.1371/journal.pone.0313475.


Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia.

Gaber M, Wilson A, Millen A, Hovey K, LaMonte M, Wactawski-Wende J Microbiome. 2024; 12(1):192.

PMID: 39367431 PMC: 11453046. DOI: 10.1186/s40168-024-01901-1.


Human Mesofluidic Intestinal Model for Studying Transport of Drug Carriers and Bacteria Through a Live Mucosal Barrier.

Wang C, Oberoi H, Law D, Li Y, Kassis T, Griffith L bioRxiv. 2024; .

PMID: 39345622 PMC: 11429741. DOI: 10.1101/2024.09.18.613692.


Multi-Omics Identified THDCA as a Key Contributor to Hyperlipidemia and as a Potential Therapeutic Agent.

Lou Z, Han L, Qu Y, Zhou A, Ye H, Yan M Rev Cardiovasc Med. 2024; 24(9):248.

PMID: 39076393 PMC: 11270126. DOI: 10.31083/j.rcm2409248.